Rajeswar Rao Vedula
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rajeswar Rao Vedula has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Krishnaiah Vaarla
Department of Chemistry, National Institute of Technology, Warangal, Telangana State, India
11 shared publications- Santhosh Penta
Department of Chemistry National Institute of Technology Raipur Chhattisgarh 492010 India
9 shared publications Raju Chedupaka
Department of Chemistry National Institute of Technology Warangal Telangana India
8 shared publicationsKodam Sujatha
Department of Chemistry, National Institute of Technology, Warangal, Telangana, India
7 shared publicationsPapisetti Venkatesham
National Institute of Technology Warangal, Telangana India. 506004
7 shared publicationsSreenu Pavurala
Department of Chemistry, National Institute of Technology, Warangal, India
7 shared publications
Latest Publications
- 30 July 2024
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 61 (10) , 1586-1596
An efficient one‐pot, three‐component synthesis of novel [1,2,4]triazolo [4′,3′:1,5][1,2,4]triazolo[3,4‐b][1,3,4]thiadiazine derivatives and their molecular docking studies
A series of novel [1,2,4]triazolo[4′,3′:1,5][1,2,4]triazolo[3,4‐b][1,3,4]thiadiazines (4a‐p) were synthesized from the reaction of 4‐amino‐5‐hydrazinyl‐4H‐1,2,4‐triazole‐3‐thiol (1) with different bromoethanones (2a‐p) and substituted benzoic acids (3) via a one‐pot, three‐component reaction with good to excellent yields. The new fused tri‐cyclic system was achieved without using a catalyst and metal by cyclo‐condensation reaction through a one‐pot approach. The structures of newly synthesized molecules were confirmed by using IR, 1H‐NMR, 13C‐NMR, Mass spectral, and analytical data. Molecular docking studies were carried out for the newly synthesized compounds against human cancer receptors (2TKB) with good results.
- 30 July 2024
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 61 (10) , 1586-1596
An efficient one‐pot, three‐component synthesis of novel [1,2,4]triazolo [4′,3′:1,5][1,2,4]triazolo[3,4‐b][1,3,4]thiadiazine derivatives and their molecular docking studies
A series of novel [1,2,4]triazolo[4′,3′:1,5][1,2,4]triazolo[3,4‐b][1,3,4]thiadiazines (4a‐p) were synthesized from the reaction of 4‐amino‐5‐hydrazinyl‐4H‐1,2,4‐triazole‐3‐thiol (1) with different bromoethanones (2a‐p) and substituted benzoic acids (3) via a one‐pot, three‐component reaction with good to excellent yields. The new fused tri‐cyclic system was achieved without using a catalyst and metal by cyclo‐condensation reaction through a one‐pot approach. The structures of newly synthesized molecules were confirmed by using IR, 1H‐NMR, 13C‐NMR, Mass spectral, and analytical data. Molecular docking studies were carried out for the newly synthesized compounds against human cancer receptors (2TKB) with good results.
- 9 July 2024
- Published by Springer Nature in Chemistry Africa
- Vol. 7 (7) , 1-17
Nano Based Thiazole as a Potent Anticancer Agent and its In-Silico Molecular Docking and ADMET Prediction Studies
- 9 July 2024
- Published by Springer Nature in Chemistry Africa
- Vol. 7 (7) , 1-17
Nano Based Thiazole as a Potent Anticancer Agent and its In-Silico Molecular Docking and ADMET Prediction Studies
- 18 October 2023
- Published by Wiley in ChemistrySelect
- Vol. 8 (39)
Efficient Four‐Component Synthesis of 1,2,4‐Triazolo[1,5‐ a ]pyrimidines and Their In Vitro Antiproliferative Studies
Triazolopyrimidines are emerging as potential anticancer agents. Herein, we report a novel one‐pot four component synthesis of 2‐((2‐oxo‐2‐phenylethyl/benzyl)thio)‐10‐phenyl‐4,10‐dihydro‐9 H ‐indeno[1,2‐ d ][1,2,4]‐Triazolo[1,5‐ a ]pyrimidin‐9‐ones by the reaction of 1,3‐indanedione, aromatic aldehyde, 5‐amino‐4 H ‐1,2,4‐Triazol‐3‐thiol and phenacyl bromide in acetic acid with piperidine as catalyst at 90 °C for 13 hours. All the final compounds were identified on the basis of their FT‐IR, 1 H NMR, 13 C NMR and HRMS. The synthesized compounds were evaluated for their cell growth inhibition potential using MTT and wound healing assay, 13 compounds induced concentration dependent inhibition with IC 50 below 10 μM against breast cancer cell lines (MCF‐7). Further, the molecular docking simulation were carried out for all the derivatives, amongst these thio phenacyl, 2,4‐dichlorophenyl 9 H ‐indeno [1,2,4]‐Triazolo[1,5‐ a ]pyrimidin‐9‐one ( 5 g ) shows good binding interaction with amino acid residues. This is further confirmed by wound healing assay which shows that 5 g inhibits cell migration at increasing concentrations.
- 18 October 2023
- Published by Wiley in ChemistrySelect
- Vol. 8 (39)
Efficient Four‐Component Synthesis of 1,2,4‐Triazolo[1,5‐ a ]pyrimidines and Their In Vitro Antiproliferative Studies
Triazolopyrimidines are emerging as potential anticancer agents. Herein, we report a novel one‐pot four component synthesis of 2‐((2‐oxo‐2‐phenylethyl/benzyl)thio)‐10‐phenyl‐4,10‐dihydro‐9 H ‐indeno[1,2‐ d ][1,2,4]‐Triazolo[1,5‐ a ]pyrimidin‐9‐ones by the reaction of 1,3‐indanedione, aromatic aldehyde, 5‐amino‐4 H ‐1,2,4‐Triazol‐3‐thiol and phenacyl bromide in acetic acid with piperidine as catalyst at 90 °C for 13 hours. All the final compounds were identified on the basis of their FT‐IR, 1 H NMR, 13 C NMR and HRMS. The synthesized compounds were evaluated for their cell growth inhibition potential using MTT and wound healing assay, 13 compounds induced concentration dependent inhibition with IC 50 below 10 μM against breast cancer cell lines (MCF‐7). Further, the molecular docking simulation were carried out for all the derivatives, amongst these thio phenacyl, 2,4‐dichlorophenyl 9 H ‐indeno [1,2,4]‐Triazolo[1,5‐ a ]pyrimidin‐9‐one ( 5 g ) shows good binding interaction with amino acid residues. This is further confirmed by wound healing assay which shows that 5 g inhibits cell migration at increasing concentrations.
- 12 September 2023
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 60 (12) , 1989-1998
Novel one‐pot synthesis of imidazo[2,1‐b] [1, 2, 4]‐Triazoles, 1,2,4‐Triazolo iminoindoline‐2‐ones, and their in‐vitro antibacterial activity,B‐DNAstudy
New series of 2‐(benzylthio)‐6‐phenyl‐4H‐imidazo[1,2‐b][1,2,4]‐Triazoles and benzylthio‐4H‐1,2,4‐Triazolo iminoimdoline‐2‐ones have been synthesized via a one‐pot process. Further, all the synthesized compounds were screened for their antibacterial activity against Gram‐positive, Gram‐negative bacteria. Among these tested compounds,5a–jhave shown promising antibacterial activity usingB. subtilisand studied for B‐DNA binding.
- 12 September 2023
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 60 (12) , 1989-1998
Novel one‐pot synthesis of imidazo[2,1‐b] [1, 2, 4]‐Triazoles, 1,2,4‐Triazolo iminoindoline‐2‐ones, and their in‐vitro antibacterial activity,B‐DNAstudy
New series of 2‐(benzylthio)‐6‐phenyl‐4H‐imidazo[1,2‐b][1,2,4]‐Triazoles and benzylthio‐4H‐1,2,4‐Triazolo iminoimdoline‐2‐ones have been synthesized via a one‐pot process. Further, all the synthesized compounds were screened for their antibacterial activity against Gram‐positive, Gram‐negative bacteria. Among these tested compounds,5a–jhave shown promising antibacterial activity usingB. subtilisand studied for B‐DNA binding.
- 25 July 2023
- Published by Springer Nature in Molecular Diversity
- Vol. 28 (3) , 1-12
Design, synthesis, molecular docking, and dynamic studies of novel thiazole derivatives incorporating benzimidazole moiety and assessment as antibacterial agents
A general and sustainable approach for the synthesis of benzimidazole-thiazole compounds via an efficient, one-pot, domino, pseudo-four-component reaction using 5-amino-2-mercaptobenzimidazole, aralkyl halides, ammonium thiocyanate, and substituted α-bromo-acetophenones in glacial acetic acid at ambient temperature to give final compounds (4a–p) in good yields in shorter time. The spectral data of synthesized compounds were evaluated by analytical and spectral techniques (IR, 1H-NMR, 13C-NMR, and ESI-HRMS). Further, some of the synthesized compounds were screened for their in-vitro antibacterial activity studies using the agar well diffusion method against Gram-positive Streptococcus pneumoniae (2451) bacteria and Gram-negative Proteous mirabilis (2081) bacteria. Based on the MIC results, it was observed that the most active compounds 4b, 4e, 4f, and 4k show promising antibacterial activity with the zone of inhibition values of 2.85 cm 2.75 cm, 3.6 cm, and 3.3 cm against both Gram-negative and positive bacteria cell lines, respectively. Further, we have also insight into the molecular simulation studies, based on the binding results, compound 4i showed stable binding interactions with streptomycin drug with the active site of the gyrase protein (PDB ID: 1KIJ). The structure–activity relationship (SAR) studies of all the title scaffolds were also established. The antibacterial activity, molecular docking studies, and molecular dynamic simulations of the title compounds suggested that these are promising antibacterial active skeletons. Graphical abstract
- 25 July 2023
- Published by Springer Nature in Molecular Diversity
- Vol. 28 (3) , 1-12
Design, synthesis, molecular docking, and dynamic studies of novel thiazole derivatives incorporating benzimidazole moiety and assessment as antibacterial agents
A general and sustainable approach for the synthesis of benzimidazole-thiazole compounds via an efficient, one-pot, domino, pseudo-four-component reaction using 5-amino-2-mercaptobenzimidazole, aralkyl halides, ammonium thiocyanate, and substituted α-bromo-acetophenones in glacial acetic acid at ambient temperature to give final compounds (4a–p) in good yields in shorter time. The spectral data of synthesized compounds were evaluated by analytical and spectral techniques (IR, 1H-NMR, 13C-NMR, and ESI-HRMS). Further, some of the synthesized compounds were screened for their in-vitro antibacterial activity studies using the agar well diffusion method against Gram-positive Streptococcus pneumoniae (2451) bacteria and Gram-negative Proteous mirabilis (2081) bacteria. Based on the MIC results, it was observed that the most active compounds 4b, 4e, 4f, and 4k show promising antibacterial activity with the zone of inhibition values of 2.85 cm 2.75 cm, 3.6 cm, and 3.3 cm against both Gram-negative and positive bacteria cell lines, respectively. Further, we have also insight into the molecular simulation studies, based on the binding results, compound 4i showed stable binding interactions with streptomycin drug with the active site of the gyrase protein (PDB ID: 1KIJ). The structure–activity relationship (SAR) studies of all the title scaffolds were also established. The antibacterial activity, molecular docking studies, and molecular dynamic simulations of the title compounds suggested that these are promising antibacterial active skeletons. Graphical abstract
- Open Access
- 21 July 2023
- Published by Springer Nature in Research Square
Domino, one-pot, three-component synthesis, anti-bacterial and molecular modelling studies of novel benzimidazole based isoindoline-1,3-dione and benzo[4,5]imidazo[2,1-b]thiazol hybrids
A series of metal-free, thioalkylated benzimidazole-based isoindoline-1,3-dione (4a-w) and N-fused 4,5-benzo[4,5]imidaz[2,1-b]thiazole (5a-h) derivatives were synthesized via a novel, one-pot three-component approach. All the synthesized scaffolds were well characterized by analytical and spectroscopic techniques. The usefulness of this reaction is that it involves easy workup, shorter reaction time, broad substrate scope, and column-free purification of the products. Further, the synthesized scaffolds (4a-w) were evaluated for their in-vitro anti-microbial activity using two Gram-positive and two Gram-negative bacterial cell lines Escherichia coli, Salmonella typhi, Staphylococcus aureus and Micrococcus luteus by agar well diffusion method. Among tested compounds, compounds 4a, 4g, 4j, 4q, 4s, and 4t showed significant invitro antibacterial activity against Gram-positive and Gram-negative bacterial cell lines. Further, we have also insight of molecular docking studies, based on the docking results compounds 4s, 4j, 4a, 4q, 4t, and 4g have shown stable binding interaction with streptomycin drug with active site of the B-DNA (PDB ID: 1BNA). The antibacterial activity, and molecular docking studies of the title compounds were suggested that these are promising anti-bacterial active skeletons.
- 21 July 2023
- Published by Springer Nature in Research Square
Open AccessDomino, one-pot, three-component synthesis, anti-bacterial and molecular modelling studies of novel benzimidazole based isoindoline-1,3-dione and benzo[4,5]imidazo[2,1-b]thiazol hybrids
A series of metal-free, thioalkylated benzimidazole-based isoindoline-1,3-dione (4a-w) and N-fused 4,5-benzo[4,5]imidaz[2,1-b]thiazole (5a-h) derivatives were synthesized via a novel, one-pot three-component approach. All the synthesized scaffolds were well characterized by analytical and spectroscopic techniques. The usefulness of this reaction is that it involves easy workup, shorter reaction time, broad substrate scope, and column-free purification of the products. Further, the synthesized scaffolds (4a-w) were evaluated for their in-vitro anti-microbial activity using two Gram-positive and two Gram-negative bacterial cell lines Escherichia coli, Salmonella typhi, Staphylococcus aureus and Micrococcus luteus by agar well diffusion method. Among tested compounds, compounds 4a, 4g, 4j, 4q, 4s, and 4t showed significant invitro antibacterial activity against Gram-positive and Gram-negative bacterial cell lines. Further, we have also insight of molecular docking studies, based on the docking results compounds 4s, 4j, 4a, 4q, 4t, and 4g have shown stable binding interaction with streptomycin drug with active site of the B-DNA (PDB ID: 1BNA). The antibacterial activity, and molecular docking studies of the title compounds were suggested that these are promising anti-bacterial active skeletons.
- Open Access
- 4 May 2023
- Published by Springer Nature in Research Square
One-pot, three-component synthesis, anti-bacterial and molecular modelling studies of novel benzimidazole based isoindoline-1,3-dione and benzo[4,5]imidazo[2,1-b]thiazol hybrids
A series of metal-free, thioalkylated benzimidazole-based isoindoline-1,3-dione (4a-w) and N-fused 4,5-benzo[4,5]imidaz[2,1-b]thiazole (5a-h) derivatives were synthesized via a novel, one-pot three-component approach. All the synthesized scaffolds were well characterized by analytical and spectroscopic techniques. The usefulness of this reaction is that it involves easy workup, shorter reaction time, broad substrate scope, and column-free purification of the products. Further, the synthesized scaffolds (4a-w) were evaluated for their in-vitroanti-microbial activity using two Gram-positive and two Gram-negative bacterial cell lines Escherichia coli, Salmonella typhi, Staphylococcus aureus and Micrococcus luteus by agar well diffusion method. Among tested compounds, compounds 4a, 4g, 4j, 4q, 4s, and 4t showed significant invitro antibacterial activity against Gram-positive and Gram-negative bacterial cell lines. Further, we have also insight of molecular docking studies, based on the docking results compounds 4s, 4j, 4a, 4q, 4t, and 4g have shown stable binding interaction with streptomycin drug with active site of the B-DNA (PDB ID: 1BNA). The antibacterial activity, and molecular docking studies of the title compounds were suggested that these are promising anti-bacterial active skeletons.
- 4 May 2023
- Published by Springer Nature in Research Square
Open AccessOne-pot, three-component synthesis, anti-bacterial and molecular modelling studies of novel benzimidazole based isoindoline-1,3-dione and benzo[4,5]imidazo[2,1-b]thiazol hybrids
A series of metal-free, thioalkylated benzimidazole-based isoindoline-1,3-dione (4a-w) and N-fused 4,5-benzo[4,5]imidaz[2,1-b]thiazole (5a-h) derivatives were synthesized via a novel, one-pot three-component approach. All the synthesized scaffolds were well characterized by analytical and spectroscopic techniques. The usefulness of this reaction is that it involves easy workup, shorter reaction time, broad substrate scope, and column-free purification of the products. Further, the synthesized scaffolds (4a-w) were evaluated for their in-vitroanti-microbial activity using two Gram-positive and two Gram-negative bacterial cell lines Escherichia coli, Salmonella typhi, Staphylococcus aureus and Micrococcus luteus by agar well diffusion method. Among tested compounds, compounds 4a, 4g, 4j, 4q, 4s, and 4t showed significant invitro antibacterial activity against Gram-positive and Gram-negative bacterial cell lines. Further, we have also insight of molecular docking studies, based on the docking results compounds 4s, 4j, 4a, 4q, 4t, and 4g have shown stable binding interaction with streptomycin drug with active site of the B-DNA (PDB ID: 1BNA). The antibacterial activity, and molecular docking studies of the title compounds were suggested that these are promising anti-bacterial active skeletons.
- 1 May 2023
- Published by Bentham Science Publishers Ltd. in Current Organic Synthesis
- Vol. 20 (3) , 278-307
Recent Developments in Multi-component Synthesis of Lawsone Derivatives
Background: 2-Hydroxy-1,4-Naphthoquinone (HNQ; Lawsone) is one of the most useful and the simplest naturally occurring naphthoquinones and has stimulated a resurgence of interest in the past decades due to a wide range of pharmacological activities. Introduction and Method: This activity has led to the unusually large emphasis being placed on the design of more efficient multi-component reactions (MCRs) in the synthesis of bioactive lawsone derivatives. Results and Conclusion: This review highlights the recent developments in multi-component synthesis of biologically relevant naphthoquinone linked and fused heterocyclic derivatives carried out from 2015 till now.
- 1 May 2023
- Published by Bentham Science Publishers Ltd. in Current Organic Synthesis
- Vol. 20 (3) , 278-307
Recent Developments in Multi-component Synthesis of Lawsone Derivatives
Background: 2-Hydroxy-1,4-Naphthoquinone (HNQ; Lawsone) is one of the most useful and the simplest naturally occurring naphthoquinones and has stimulated a resurgence of interest in the past decades due to a wide range of pharmacological activities. Introduction and Method: This activity has led to the unusually large emphasis being placed on the design of more efficient multi-component reactions (MCRs) in the synthesis of bioactive lawsone derivatives. Results and Conclusion: This review highlights the recent developments in multi-component synthesis of biologically relevant naphthoquinone linked and fused heterocyclic derivatives carried out from 2015 till now.
- Open Access
- 22 February 2023
- Published by Springer Nature in Research Square
Facile, One-pot, pseudo four component synthesis of novel benzimidazolyl- thiazoles via multi-component approach and their biological evaluation
A general and sustainable multicomponent approach for the synthesis of benzimidazolyl-thiazole compounds via an efficient, one-pot, pseudo four-component reaction using 5-amino-2-mercaptobenzimidazole, aralkyl halides, ammonium thiocyanate, and substituted α-bromo-acetophenones in glacial acetic acid at ambient temperature to give final compounds (4a-p) in good yields in shorter time. The spectral data of synthesized compounds were evaluated by analytical and spectral techniques (IR, 1H-NMR, 13C-NMR, and ESI-HRMS). Further, some of the synthesized compounds were screened for their in-vitro antibacterial activity studies using the agar well diffusion method against Gram-positive Streptococcus Pneumoniae (2451) bacteria and Gram-negative Porteous Mirabilis (2081) bacteria. Based on the MIC results, it was observed that the most active compounds 4b, 4e, 4f, and 4k are shown promising anti-bacterial activity with the zone of inhibition values of 2.85 cm 2.75 cm, 3.6 cm, and 3.3 cm against both Gram-negative and Gram-positive bacteria cell lines respectively. Further, we have also insight into the molecular simulation studies, based on the binding results, compound 4i showed stable binding interactions with streptomycin drug with active site of the gyrase protein (PDB ID: 1KIJ). The structure-activity relationship (SAR) studies of all the title scaffolds were also established. The antibacterial activity, molecular docking studies, molecular dynamic simulations of the title compounds were suggested that these are promising anti-bacterial active skeletons.
- 22 February 2023
- Published by Springer Nature in Research Square
Open AccessFacile, One-pot, pseudo four component synthesis of novel benzimidazolyl- thiazoles via multi-component approach and their biological evaluation
A general and sustainable multicomponent approach for the synthesis of benzimidazolyl-thiazole compounds via an efficient, one-pot, pseudo four-component reaction using 5-amino-2-mercaptobenzimidazole, aralkyl halides, ammonium thiocyanate, and substituted α-bromo-acetophenones in glacial acetic acid at ambient temperature to give final compounds (4a-p) in good yields in shorter time. The spectral data of synthesized compounds were evaluated by analytical and spectral techniques (IR, 1H-NMR, 13C-NMR, and ESI-HRMS). Further, some of the synthesized compounds were screened for their in-vitro antibacterial activity studies using the agar well diffusion method against Gram-positive Streptococcus Pneumoniae (2451) bacteria and Gram-negative Porteous Mirabilis (2081) bacteria. Based on the MIC results, it was observed that the most active compounds 4b, 4e, 4f, and 4k are shown promising anti-bacterial activity with the zone of inhibition values of 2.85 cm 2.75 cm, 3.6 cm, and 3.3 cm against both Gram-negative and Gram-positive bacteria cell lines respectively. Further, we have also insight into the molecular simulation studies, based on the binding results, compound 4i showed stable binding interactions with streptomycin drug with active site of the gyrase protein (PDB ID: 1KIJ). The structure-activity relationship (SAR) studies of all the title scaffolds were also established. The antibacterial activity, molecular docking studies, molecular dynamic simulations of the title compounds were suggested that these are promising anti-bacterial active skeletons.
- 18 April 2022
- Published by Taylor & Francis in Synthetic Communications
- Vol. 52 (8) , 1111-1121
Synthesis, characterization and Density Functional Theory of novel one-pot thioalkylated benzimidazole-linked 4-substituted mercaptoimidazole molecular hybrids via multi-component approach
A series of novel, one-pot, four components synthetic procedure has been developed for the synthesis of thioalkylated benzimidazole-linked 4-substituted mercaptoimidazole molecular hybrids and their benzyl derivatives (4a–j) and (5a–f) were synthesized by the reaction of 5-amino-2-mercaptobenzimidazole, with different substituted phenacyl bromides/aryl alkyl halides in the presence of glacial acetic acid and fused sodium acetate under reflux condition to give corresponding intermediates. These compounds on further reaction with ammonium thiocyanate via multi-component reaction to give the title compounds (4a–j) and (5a–f). All the newly synthesized compounds were well characterized by their spectral and analytical studies. This procedure includes several advantages such as transition metal-free, catalyst-free, mild reaction temperature, shorter reaction time, and gives good to excellent yields without any column purification techniques. Further, mechanistic insight into the formation of the final products has also been provided based on their density functional theory (DFT) studies. Graphical Abstract
- 18 April 2022
- Published by Taylor & Francis in Synthetic Communications
- Vol. 52 (8) , 1111-1121
Synthesis, characterization and Density Functional Theory of novel one-pot thioalkylated benzimidazole-linked 4-substituted mercaptoimidazole molecular hybrids via multi-component approach
A series of novel, one-pot, four components synthetic procedure has been developed for the synthesis of thioalkylated benzimidazole-linked 4-substituted mercaptoimidazole molecular hybrids and their benzyl derivatives (4a–j) and (5a–f) were synthesized by the reaction of 5-amino-2-mercaptobenzimidazole, with different substituted phenacyl bromides/aryl alkyl halides in the presence of glacial acetic acid and fused sodium acetate under reflux condition to give corresponding intermediates. These compounds on further reaction with ammonium thiocyanate via multi-component reaction to give the title compounds (4a–j) and (5a–f). All the newly synthesized compounds were well characterized by their spectral and analytical studies. This procedure includes several advantages such as transition metal-free, catalyst-free, mild reaction temperature, shorter reaction time, and gives good to excellent yields without any column purification techniques. Further, mechanistic insight into the formation of the final products has also been provided based on their density functional theory (DFT) studies. Graphical Abstract